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Method
To develop the National Drug Supply Chain Management
Strategy (SCM) Strategy, BinFar formed a strategy team
made up of key SCM partners and staff. A drug SCM
situation analysis was undertaken in 14 units within the
MOH, exploring SCM issues and concerns, including staff
development. Based on the results of the situation analysis,
a stakeholders meeting was held to determine the core
substance of the strategy and build a consensus on the key
issues, including human resource development.
Results
A national drug SCM strategy was developed to ensure
drug availability, drug quality, and drug affordability for
the public. The strategy framework included challenges
and opportunities, a Vision, Mission and Goal statements,
and developed strategy components based on the tradi-
tional SCM cycle. Based on the situation analysis results
and in depth discussion with stakeholders, the strategy
reviews each SCM cycle component regarding challenges
and current practices and experiences. Based on these fac-
tors, a specific component strategy was developed with
several strategic measures. It was concluded that human
resource development was essential to support the entire
drug management system.
Discussion
To support the national drug SCM strategy, the following
is needed:
1. Development of pharmacists competent as drug
managers at all levels, including at health service facil-
ities in hospitals and health centres.
2. Trained SCM personnel to ensure the smooth run-
ning of the drug management information systems.
The following strategies have been suggested to move
this agenda forward:
1. Complete task analysis for every SCM competency
required and develop pre-service and in-service train-
ing for pharmacists.
2. Stipulate a personnel standard for service loca-
tions that include pharmacists trained in SCM.
Lessons learned
A national drug SCM strategy is a good opportunity to
identify human resource SCM needs.
Obtaining consensus across programs and departments
for a national drug SCM strategy requires strong baseline
data and considerable dialogue.
Human resource issues and solutions are the backbone
of a national drug SCM strategy.
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